Purchase Order STH20015M3389
Award Date
9/16/15
Potential Completion Date
11/30/15
Potential Value
$138K
Funding Federal Agency
Department of Health and Human Services
Contracting Federal Agency
US Embassy Bangkok
Awardee
Bio-Active Company LIMITED
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Thailand
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Bio-Active Company LIMITED, a for-profit limited liability company, for the acquisition of lab reagents for whole genome sequencing with Illumina instruments on behalf of the CDC's Division of Global Health Protection (DGHP) in Thailand. The contract, valued at $81,470.59, has an ultimate completion date of October 31, 2024. Bio-Active Company LIMITED has a history of delivering genetic...
This firm fixed price contract was awarded to Bio-Active Company LIMITED, a for-profit limited liability company, to provide services on the Illumina MiSeq sequencing system. The $27,344.86 contract is a call against a previously awarded Blanket Purchase Agreement to support infectious disease monitoring and research conducted by U.S. government health agencies, including the Centers for Disease Control and Prevention (CDC), operating programs in Thailand. No set-aside was used for this award....
This federal contract award is for "SERVICES ON MISEQ SYSTEM" to be provided by Bio-Active Company LIMITED, a for-profit limited liability company, to the Centers for Disease Control and Prevention (CDC) operating out of a facility in Thailand. The contract, valued at $26,438.95, is a firm fixed price Blanket Purchase Agreement (BPA) call, with a period of performance ending on August 31, 2023. The contract does not have a set-aside designation. Bio-Active Company LIMITED has...
This federal contract award is for services related to the Illumina MiSeq genetic sequencing system. The $26,537.08 firm fixed price contract was issued as a call under a Blanket Purchase Agreement (BPA) held by Bio-Active Company Limited, a for-profit limited liability company based in Thailand. The work is being performed for the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian federal agency. No set-aside designation was used for this award. Bio-Active Company...
This is a firm fixed price purchase order awarded by the Department of Defense, Bureau of Medicine and Surgery, to Bio-Active Company LIMITED, a for-profit limited liability company in Thailand. The $96,091.00 contract is for preventive maintenance on an Illumina MiSeq genetic sequencing system. This purchase order is not associated with a larger contract vehicle, and no set-aside designation was used. Based on Bio-Active Company LIMITED's past awards for biomedical goods and services to support...
This is a firm fixed price contract awarded by the Office of Intergovernmental and External Affairs, a civilian agency, to Bio-Active Company LIMITED, a for-profit limited liability company, to provide services on the Illumina MiSeq genetic sequencing system. The contract has a ceiling value of $27,212.02 and a period of performance through August 31, 2025. This is a call order issued against a previously established Blanket Purchase Agreement held by Bio-Active Company LIMITED to provide...
This is a firm fixed price purchase order awarded by the Chief of Naval Operations (CNO), a Defense agency, to Bio-Active Company LIMITED, a for-profit limited liability company. The contract is to provide Illumina sequencing systems, reagents, and testing materials to support infectious disease monitoring and research conducted by the U.S. government in Thailand. The total ceiling value of the purchase order is $35,043.75, and the period of performance runs through May 2, 2023. This award...
This is a firm fixed price contract awarded by the Office of the Secretary of Defense to Bio-Active Company LIMITED, a for-profit limited liability company, to provide maintenance and emergency services for an Illumina MiSeq genetic sequencing instrument located in Thailand. The contract, valued at $29,088.00, is a call against a pre-existing Blanket Purchase Agreement to support infectious disease monitoring and research efforts by various U.S. government agencies, including the Centers for...
This is a firm fixed price contract awarded to Bio-Active Company LIMITED, a for-profit limited liability company, by the U.S. Department of Defense's Medical Command (MEDCOM). The contract provides for services related to the operation and maintenance of Illumina MiSeq genetic sequencing systems used to support infectious disease monitoring and research in Thailand. The award, valued at $27,615.93, is a call against a previously established Blanket Purchase Agreement between Bio-Active...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $47,610.00 firm fixed price purchase order to Bio-Active Company LIMITED, a for-profit limited liability company in Thailand. The contract is for an annual maintenance agreement to support the NIAID's Illumina NextSeq 2000 genetic sequencing system in Cambodia. This award is not associated with a larger contract vehicle. No set-aside designations were used. Bio-Active Company LIMITED has previously...